Orfit Pharmaceuticals Private Limited - Company Profile

It is a business services private limited company based in Delhi, Delhi, India, established in 2024.
2024 Delhi, Delhi, India Active
Last Updated:
Access Report
About Orfit Pharmaceuticals Private Limited

Orfit Pharmaceuticals Private Limited, a active private limited company, was established on 06 November 2024 in Delhi, Delhi, India. it holds CIN: U46497DL2024PTC438434. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹1.00 M.

Its leadership includes Pritam Kumar Gupta (Director), Deepak Kumar (Director), Anu Sinha (Director). Past directors included Simpal Kumari. It is based at Kh. No. 25/21, Ground Floor, Street No-4, Village Jharoda Majra, Sangam Vihar City, Delhi, Delhi, 110084.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U46497DL2024PTC438434

  • Registration Number

    438434

  • Incorporation Date

    06 November 2024

  • Authorized Capital

    ₹1.00 M

  • Paid-Up Capital

    ₹1.00 M

  • ROC Code

    Roc Delhi

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.00 M
  • Paid Up Capital ₹ 1.00 M
  • Company Age 1 Year 4 Months
Company report

Orfit Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Orfit Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Orfit Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Pritam Kumar Gupta Director 06 Nov 2024 Current
Deepak Kumar Director 18 Jun 2025 Current
Anu Sinha Director 18 Jun 2025 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 18 Jun 2025 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Orfit Pharmaceuticals.

Enhance accessibility to Orfit Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Orfit Pharmaceuticals revenue growth over time
Orfit Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Orfit Pharmaceuticals?

Unlock access to Orfit Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Orfit Pharmaceuticals?

Unlock and access historical data on people associated with Orfit Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Orfit Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Orfit Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Orfit Pharmaceuticals
Recent Activity within the Organization
  • Director Appointment

    Deepak Kumar was appointed as a Director was appointed as a Director on 18 Jun 2025 & has been associated with this company since 8 months 22 days . was recorded as a recent event.

  • Director Appointment

    Progress on Anu Sinha was appointed as a Director was appointed as a Director on 18 Jun 2025 & has been associated with this company since 8 months 22 days . was documented.

  • Director Appointment

    Pritam Kumar Gupta was appointed as a Director was appointed as a Director on 06 Nov 2024 & has been associated with this company since 1 year 4 months . was recorded as a recent event.

  • Company Incorporation

    The activity Orfit Pharmaceuticals Private Limited was registered on 06 Nov 2024 with Roc Delhi & aged 1 year 4 months as per MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Orfit Pharmaceuticals Private Limited?

The CIN of Orfit Pharmaceuticals Private Limited is U46497DL2024PTC438434.

Where is Orfit Pharmaceuticals Private Limited headquartered?

Orfit Pharmaceuticals Private Limited is headquartered at Kh. No. 25/21, Ground Floor, Street No-4, Village Jharoda Majra, Sangam Vihar City, Delhi, Delhi, 110084.

When was Orfit Pharmaceuticals Private Limited incorporated?

Orfit Pharmaceuticals Private Limited was incorporated on 06 November 2024.

Who are the current directors of Orfit Pharmaceuticals Private Limited?

The current directors of Orfit Pharmaceuticals Private Limited are

Is Orfit Pharmaceuticals Private Limited a listed company?

Orfit Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Orfit Pharmaceuticals Private Limited?

The authorized capital of Orfit Pharmaceuticals Private Limited is ₹1.00 M, and the paid-up capital is ₹1.00 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available